Ergoteles’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-52,188
| Closed | -$1.25M | – | 30 |
|
|
2023
Q2 | $1.25M | Buy |
52,188
+16,062
| +44% | +$385K | 0.06% | 396 |
|
|
2023
Q1 | $680K | Sell |
36,126
-101,429
| -74% | -$1.91M | 0.03% | 634 |
|
|
2022
Q4 | $2.19M | Sell |
137,555
-120,742
| -47% | -$1.92M | 0.08% | 253 |
|
|
2022
Q3 | $4.23M | Buy |
258,297
+240,741
| +1,371% | +$3.94M | 0.15% | 147 |
|
|
2022
Q2 | $247K | Buy |
+17,556
| New | +$247K | 0.01% | 1210 |
|
|
2022
Q1 | – | Sell |
-26,637
| Closed | -$622K | – | 1167 |
|
|
2021
Q4 | $622K | Buy |
26,637
+4,211
| +19% | +$98.3K | 0.02% | 565 |
|
|
2021
Q3 | $372K | Buy |
+22,426
| New | +$372K | 0.01% | 709 |
|
|
2021
Q2 | – | Sell |
-161,892
| Closed | -$4.18M | – | 1456 |
|
|
2021
Q1 | $4.18M | Buy |
161,892
+97,758
| +152% | +$2.52M | 0.13% | 186 |
|
|
2020
Q4 | $3.43M | Buy |
+64,134
| New | +$3.43M | 0.11% | 186 |
|